Publication:
Stress kinases in the development of liver steatosis and hepatocellular carcinoma.

dc.contributor.authorCicuéndez, Beatriz
dc.contributor.authorRuiz-Garrido, Irene
dc.contributor.authorMora, Alfonso
dc.contributor.authorSabio, Guadalupe
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)es_ES
dc.contributor.funderFundación BBVAes_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.contributor.funderAsociación Española Contra el Cánceres_ES
dc.contributor.funderComunidad de Madrid (España)es_ES
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)es_ES
dc.contributor.funderFundación ProCNICes_ES
dc.date.accessioned2024-03-11T14:26:26Z
dc.date.available2024-03-11T14:26:26Z
dc.date.issued2021-08
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) is an important component of metabolic syndrome and one of the most prevalent liver diseases worldwide. This disorder is closely linked to hepatic insulin resistance, lipotoxicity, and inflammation. Although the mechanisms that cause steatosis and chronic liver injury in NAFLD remain unclear, a key component of this process is the activation of stress-activated kinases (SAPKs), including p38 and JNK in the liver and immune system. This review summarizes findings which indicate that the dysregulation of stress kinases plays a fundamental role in the development of steatosis and are important players in inducing liver fibrosis. To avoid the development of steatohepatitis and liver cancer, SAPK activity must be tightly regulated not only in the hepatocytes but also in other tissues, including cells of the immune system. Possible cellular mechanisms of SAPK actions are discussed.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipWe thank S. Bartlett for English editing. GS receives funding from the European Union Seventh Framework Programme (FP7/2007-2013) ERC 260464, the EFSD/Lilly European Diabetes Research Programme, a Leonardo Grant for Researchers and Cultural Creators from the BBVA Foundation (Investigadores-BBVA-2017) IN[17] _BBM_BAS_0066, the Ministerio de Economia y Competitividad (MINECO-FEDER SAF2016-79126-R and PID2019-104399RB-I00), the Fundación AECC (PROYE19047SABI), and the Comunidad de Madrid (IMMUNOTHERCAN-CM S2010/ BMD-2326 and B2017/BMD-3733). The CNIC is supported by the Ministerio de Ciencia, Innovación y Universidades (MCNU)Ministerio de Ciencia, Innovación y Universidades, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505). We thank our collaborators and all the students and fellows who have contributed to studies in the Sabio group over the years. We regret the inadvertent omission of important references due to space limitationses_ES
dc.format.page101190es_ES
dc.format.volume50es_ES
dc.identifier.citationMol Metab. 2021 Aug:50:101190.es_ES
dc.identifier.doi10.1016/j.molmet.2021.101190es_ES
dc.identifier.e-issn2212-8778es_ES
dc.identifier.journalMolecular metabolismes_ES
dc.identifier.pubmedID33588102es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18916
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SAF2016-79126-Res_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-104399RB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PROYE19047SABIes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/IMMUNOTHERCAN-CM S2010/BMD-2326es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/B2017/BMD-3733es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SEV-2015-0505es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/ERC/260464es_ES
dc.relation.publisherversion10.1016/j.molmet.2021.101190es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Papel de las quinasas activadas por el estrés en el desarrollo de enfermedades cardiovasculares, diabetes y cánceres_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshMAP Kinase Signaling Systemes_ES
dc.subject.meshAnimalses_ES
dc.subject.meshAutophagyes_ES
dc.subject.meshCarcinoma, Hepatocellulares_ES
dc.subject.meshDisease Models, Animales_ES
dc.subject.meshHumanses_ES
dc.subject.meshInsulin Resistancees_ES
dc.subject.meshJNK Mitogen-Activated Protein Kinaseses_ES
dc.subject.meshLiveres_ES
dc.subject.meshLiver Neoplasmses_ES
dc.subject.meshNon-alcoholic Fatty Liver Diseasees_ES
dc.subject.meshProtective Agentses_ES
dc.subject.meshp38 Mitogen-Activated Protein Kinaseses_ES
dc.titleStress kinases in the development of liver steatosis and hepatocellular carcinoma.es_ES
dc.typereview articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationbc42fc37-5614-4176-852f-4210784143e8
relation.isAuthorOfPublication7de1300f-8563-434d-b693-41b7c8c6fdd1
relation.isAuthorOfPublication.latestForDiscoverybc42fc37-5614-4176-852f-4210784143e8

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Stress kinases_Mol Metab_2021.pdf
Size:
2.01 MB
Format:
Adobe Portable Document Format
Description: